|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
70,932,000 |
Market
Cap: |
7.02(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$46.95 - $104.57 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
125,539 |
320,695 |
527,446 |
1,090,075 |
Total Sell Value |
$11,041,612 |
$23,513,979 |
$35,732,025 |
$60,263,925 |
Total People Sold |
4 |
8 |
9 |
11 |
Total Sell Transactions |
11 |
21 |
48 |
99 |
End Date |
2025-07-06 |
2025-04-04 |
2024-10-04 |
2023-10-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shulman Joseph |
Chief Technical Officer |
|
2025-09-02 |
4 |
AS |
$105.30 |
$1,767,006 |
D/D |
(16,781) |
8,509 |
|
-5% |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-09-02 |
4 |
OE |
$27.35 |
$507,574 |
D/D |
16,781 |
25,290 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-08-21 |
4 |
AS |
$100.07 |
$419,091 |
D/D |
(4,188) |
8,509 |
|
-3% |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-08-21 |
4 |
OE |
$27.35 |
$114,542 |
D/D |
4,188 |
12,697 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-08-13 |
4 |
AS |
$96.00 |
$333,792 |
D/D |
(3,477) |
116,915 |
|
1% |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-08-13 |
4 |
OE |
$6.88 |
$23,922 |
D/D |
3,477 |
120,392 |
|
- |
|
German Christopher Paul |
Corporate Controller & CAO |
|
2025-08-12 |
4 |
AS |
$95.00 |
$142,500 |
D/D |
(1,500) |
922 |
|
3% |
|
German Christopher Paul |
Corporate Controller & CAO |
|
2025-08-12 |
4 |
OE |
$17.97 |
$42,585 |
D/D |
1,500 |
1,422 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-08-12 |
4 |
AS |
$96.33 |
$2,370,832 |
D/D |
(24,611) |
116,915 |
|
3% |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-08-12 |
4 |
OE |
$6.88 |
$169,324 |
D/D |
24,611 |
141,526 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-08-11 |
4 |
AS |
$90.08 |
$358,891 |
D/D |
(3,984) |
8,509 |
|
5% |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-08-11 |
4 |
OE |
$6.80 |
$27,091 |
D/D |
3,984 |
12,493 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2025-07-29 |
4 |
AS |
$85.93 |
$130,614 |
D/D |
(1,520) |
20,814 |
|
16% |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2025-07-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
22,334 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-07-09 |
4 |
AS |
$75.38 |
$3,389,756 |
D/D |
(42,120) |
116,915 |
|
11% |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-07-09 |
4 |
OE |
$6.88 |
$289,786 |
D/D |
42,120 |
159,035 |
|
- |
|
German Christopher Paul |
Corporate Controller & CAO |
|
2025-07-09 |
4 |
AS |
$76.75 |
$308,217 |
D/D |
(3,817) |
922 |
|
11% |
|
German Christopher Paul |
Corporate Controller & CAO |
|
2025-07-09 |
4 |
OE |
$17.97 |
$77,786 |
D/D |
2,850 |
4,739 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2025-07-09 |
4 |
AS |
$75.55 |
$1,201,062 |
D/D |
(15,572) |
19,209 |
|
11% |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2025-07-09 |
4 |
OE |
$6.80 |
$209,153 |
D/D |
15,572 |
34,781 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-07-09 |
4 |
AS |
$75.56 |
$619,851 |
D/D |
(7,969) |
8,509 |
|
11% |
|
Shulman Joseph |
Chief Technical Officer |
|
2025-07-09 |
4 |
OE |
$6.80 |
$54,189 |
D/D |
7,969 |
16,478 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2025-07-07 |
4 |
OE |
$6.88 |
$48,064 |
D/D |
6,986 |
116,915 |
|
- |
|
Garfield Alastair |
Chief Scientific Officer |
|
2025-07-02 |
4 |
AS |
$64.60 |
$85,483 |
D/D |
(1,319) |
3,126 |
|
48% |
|
Garfield Alastair |
Chief Scientific Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,445 |
4,445 |
|
- |
|
382 Records found
|
|
Page 1 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|